chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm hurt,; whole body was hurting; couldn't stop shaking,; and had a temperature of 101°F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt,), MYALGIA (whole body was hurting), TREMOR (couldn't stop shaking,) and BODY TEMPERATURE INCREASED (and had a temperature of 101°F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (ATORVASTIN) and THYRODEX T 150 for an unknown indication.    On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Dec-2021, the patient experienced PAIN IN EXTREMITY (arm hurt,), MYALGIA (whole body was hurting), TREMOR (couldn't stop shaking,) and BODY TEMPERATURE INCREASED (and had a temperature of 101°F). The patient was treated with IBUPROFEN for Body temperature increased, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm hurt,), MYALGIA (whole body was hurting) and TREMOR (couldn't stop shaking,) outcome was unknown and BODY TEMPERATURE INCREASED (and had a temperature of 101°F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Dec-2021, Body temperature: 101 (High) 101°F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Dermatitis, my entire face has broken out in a rash, extremely itchy, red, my lips had blisters. I took steroids, antibiotics and other creams to try and help it. It is now breaking out again, only a week or two after finally subsiding.
Information has been received from a physician concerning his middle school aged grandson who ten years ago, in approximately 1996, was vaccinated with a dose of Varivax. In March 2006 the patient experienced breakthrough varicella. It was noted that the patient had less than 50 lesions. Subsequently, the patient recovered from varicella on an unspecified date. No product quality complaint was involved. Additional information has been requested.
Vaccine was on Wednesday November 10th, on Friday morning I woke up short of breath. By afternoon I was short of breath with severe heart palpitations and went to the emergency room. Bloodwork determined I now have hyperthyroidism, which is I did not have before. Follow-up blood work November 17th confirmed the diagnosis and now waiting to see a specialist.
Sore Throat and fatigue; Sore Throat and fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat and fatigue) and FATIGUE (Sore Throat and fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore Throat and fatigue) and FATIGUE (Sore Throat and fatigue). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat and fatigue) and FATIGUE (Sore Throat and fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Fever, started at 102 but kept around 99-100 with medication. Body aches, headache, chills
While breast feeding, she grabbed moms shirt, arms and legs got stiff, eyes got big and wide staring x 30 seconds, temp 101.4, vomited 2x. Had 3 more similar episodes.
treatment of COVID-19; treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Feb2023 as dose 7 (booster), single (batch/lot number: unknown) at the age of 65 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (batch/lot number: unknown), as dose 2, single (batch/lot number: unknown), as dose 3 (booster), single (batch/lot number: unknown), as dose 4 (booster), single (batch/lot number: unknown), as dose 5 (booster), single (batch/lot number: unknown) and as dose 6 (booster), single (batch/lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "myasthenia gravis" (unspecified if ongoing); "coronary artery disease" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as " treatment of COVID-19". The patient underwent the following laboratory tests and procedures: Covid-19 test: negative, notes: rebound after 2 negative rests. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid which started from 03Apr2023 to 07Apr2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
This is a non-serious spontaneous case from a healthcare professional in the USA reporting that a medical support member had ACCIDENTAL EXPOSURE to FLUMIST while vaccinating military personnel. The reporter determined the events to be unrelated to FLUMIST administration. This case is submitted according to the VAERS accelerated reporting agreement for FLUMIST. An unidentified medical support member developed headache and scratchy throat after accidental exposure during FLUMIST administration. Investigation into these events resulted in no definitive reason why the FLUMIST was responsible for these symptoms. The reporter determined the events to be unrelated to FLUMIST vaccination. Further information has been requested. Follow up - This is a non-serious spontaneous case from a healthcare professional reporting that a medical support member had ACCIDENTAL EXPOSURE to FLUMIST while vaccinating military personnel. The reporter determined the events to be unrelated to FLUMIST administration. This case is submitted according to the VAERS accelerated reporting agreement for FLUMIST. An unidentified medical support member developed headache and scratchy throat after accidental exposure during FLUMIST administration. Investigation into these events resulted in "no definitive reason" why the FLUMIST was responsible for "these symptoms." HEPA filters were put into the environment and since then, nobody has gottensick. The patient has recovered. The reporter believes military personnel that were vaccinated with FLUMIST were already sick and hence may have caused the individuals administering FLUMIST to have headache and scratchy throat. The reporter will not give patient identifiers regarding this patient. The reporter determined the events to be unrelated to FLUMIST vaccination. Additional information received on 05Jan05 and 19Jan05 incorporated into above narrative.
Blood clots in left leg from ankle to groin and smaller clots in both lungs. Intravenous filter installed before heart and placed on permanent blood thinners. Only symptoms related were some slight discomfort and swelling in the left leg.
sweating; loss of appetite; diarrhea; vomitting lasted for a day; chills; could hardly eat anything for 5 days; This is a follow up spontaneous received from a contactable Consumer (patient). This 60-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (manufacturer: Unspecified) first dose on 11MAR2021 2 weeks ago (Lot: EN6207, NDC/UPC number: Unknown, Expiry Date: Unknown) at single dose for COVID-19 immunisation. Medical history included COPD, allergies, asthma, all from unspecified date to unspecified date and probably diagnosed from 10-15 years ago. Concomitant medications included Montelukast, Fluconazole, Trazodone for Muscle relaxant, tiotropium bromide (SPIRIVA), oxycodone hydrochloride (OXYCONTIN) for bad back and hip replacement and all of his pain medicine, Nebulizer at 2 times a day, all from unspecified date to unspecified date and other unspecified Concomitant Products. He took a sleeping pill at night so that he could sleep. He took 'Steopus' that was 2 times in the evening for his allergies. The patient previously took multivitamin at one dose every day for couple of months for low on some Vitamins. Received on 2021-03-30 19:21:32 UTC, Originating AE Request: REQ-219680. Submitted by Call Centre 1 Reference: W2021379399; PRIMA: 21-181755. Reporter was warm connected with agent with ID reportum number 542ANWOH. Reporter received the Pfizer covid vaccine, first dose 2 weeks ago and 3 days after that he had diarrhea, vomitting lasted for a day, chills, sweating, he could hardly eat anything for 5 days. The symptoms come and went but from yesterday he stated to feel better now. Probably about 13MAR2021 was when patient first had started with diarrhea and stuff and he vomited just for one day because he had quit eating so then giving up his appetite and from then it was like he would say, it had set off yesterday but he had had chills on and off possibly all day long and all night long, not really heavy heavy sweat but sweat and loss of appetite. Reported event seriousness was unspecified. When probed if the events are improved, worsened or persisting, the patient stated they were about gone now. He was scheduled for his second shot on the first of this month, not this month the coming month. He hoped his second won't be that bad, second shot was 01APR2021. The patient underwent lab tests and procedures, which included did a lab test month and they said he was low on some Vitamins. He was low in some vitamins, he thought. The outcomes of the events was Recovered.  No follow-up attempts are needed. No further information is expected.
Pt was given immunizations, stated she felt fine during the shots and had a conversation with the technician. Pt says she got up and left the immunization clinic and was walking to the waiting area. She says she remembers going to the door and feeling warm and once she got to the door she says she doesn't remember anything else. Pt passed out in the waiting area. Pt was on floor, elevated legs, checked out by provider, vitals completed. Pt laid down for a little bit, sat her up and gave her some water to sip. Got her into chair and gave her something to eat. She hadn't eaten anything prior.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. There was no information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies reported. On 13-OCT-2016, the patient was inadvertently administered expired single dose of PNEUMOVAX 23 lot # K021577, expiry date 22-JUN-2016, intramuscularly. No adverse effects were reported. Additional information has been requested.
Massive headache, chills and shaking considerably.   Had to have ice packs on head along with multiple tylenol.  stayed in bed probably 15 hours.   When it stopped was almost immediate.
t104 2nd day x 1 day, legs very sore limp (post vax); t101 3rd day active; t104 1st day, irritable, vomitted x 1;
Nurse administered Flulaval quadrivalent 2018/2019 formula for the 2019/2020 season after medication had expired on 06/30/2019.
At time of vaccination and until I went to bed around 930PM just arm soreness. I woke up at around 120AM that night with chills, shaking, feeling hot and cold at the same time, nauseous, and fatigue all over. The chills and shaking went away by 230AM. And as as of when I'm writing this only fatigue, general unwell feeling, sore arm, and a headache remain. 130PM.
Information has been received from a medical assistant referring to unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored GARDASIL (lot # K010574 with expiration date of 08-APR-2017, dose strength and route unknown). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Light swelling and tenderness for a day or two after injection. 10 days later injection site swelled twice as much as it originally did and a few lymph nodes in my neck seemed to be tender. Both went away completely after 2 to 3 days.   Ps. The first number of the vaccine ?lot? number might be a 6. The hand writing is bad.
Nausea - headache - dizziness - exhaustion - injection site inflammation - swelling, redness and pain.
PT treated w/oral DPH a/dose #3 of vax & had hives in 15 minutes;
Pt received booster dose but this is not currently recommended for ages below 18 and pt is 17 years old.
H&H decreased along with RBC Indices. RDW increased and thrombocytosis( plt = 517,000). I usually donate RBC apheresed units of blood and only have a history of anemia during pregnancy and I am not currently pregnant.
Vaccines given on Thursday 9/15/16. SISx of bacterial cellulitis developed on 9/16/16. Patient went to an outpatient clinic and was given antibiotic and dx.
All old joint injury's "flared" up. I could not use either wrist, Knees, ankles, back, L shoulder. Any Joint that I had previously injured now felt like a new injury. Nothing would take away the pain. I would go to bed crying because I hurt in so many places, so bad. Different areas resolved quicker, but I was wearing wrist splints for 3 wks.  Even now there will be days that all of a sudden every joint hurts. I can't do anything to decrease the pain. it will resolve in 24-48hrs, but I don't know when it will strike again.
Swelling, redness and pain on right arm at site of immunization. Starting day of administration with fever, vomiting and diarrhea.
This patient complained of nausea, swelling where shot was given, redness, and tenderness a few hours after her shot was given.
Onset of bilateral underarm eczema four days after immunization and persisting through the current date which is 14 days after emergence. No prior history of eczema.  No other post-vaccine symptoms or outcomes.
Pain in upper back began evening of 11/27 and persisted. Feared a heart attack so went to the ER 11/29.  Ruled out heart attack and treated for other GI symptoms, tested negative for COVID.  Later that week tested positive for COVID (exposure at hospital?).  Burning and pain started on chest, opposing side of the back pain.  On 12/5 a rash developed on the irritated chest area below the breast.  Shingles suspected.  Had phone appointment with Dr on 12/7 and he ordered Valtrex.  Symptoms improved therefore Shingles outbreak was a positive diagnosis per Dr office.
This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a 11-year-old male patient who received MENVEO (batch number M16093, expiry date 31st March 2019). On 9th March 2017, the patient received the 1st dose of MENVEO (intramuscular) .5 ml. On 9th March 2017, less than a day after receiving MENVEO, the patient experienced injection site erythema, injection site swelling, injection site tenderness, allergic reaction and erythematous rash. On 10th March 2017, the patient experienced injection site warmth, injection site rash, injection site itching, fever and injection site urticaria. On 18th March 2017, the patient experienced conjunctivitis. The patient was treated with ibuprofen, medication unknown (Ice Pack), Cortisone Cream and Anti-Itch Cream. MENVEO was continued with no change. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site warmth, injection site rash, injection site itching, injection site tenderness, fever, injection site urticaria and erythematous rash were recovered/resolved and the outcome of the conjunctivitis and allergic reaction were unknown. The reporter considered the injection site erythema and injection site tenderness to be possibly related to MENVEO. It was unknown if the reporter considered the injection site swelling, injection site warmth, injection site rash, injection site itching, conjunctivitis, fever, injection site urticaria, allergic reaction and erythematous rash to be related to MENVEO. Additional details were provided as follows: The patient received MENVEO on Right deltoid. After vaccination, the patient experienced right deltoid tenderness, redness and swelling at the site. The mother denied fever and treated the events with Ibuprofen. On 10th March 2017, 1 day after vaccination the injection site issues were still continued and also included fever (100.4 degree F) and injection site rash which was itchy, red and swollen. The patient's mother applied old packs, used cortisone cream and anti-itch cream with little relief. On 10th March 2017 at 2:13 PM, the patient was seen by the physician and the patient's temperature was 99 degree F by temporal artery and the right upper arm was described by the doctor as pink, warm with a rash but not tender. He suspected possible urticarial in nature, but stated no cellulitis. The physician contacted an allergist to determine if that allergic reaction would contradict the patient from receiving future doses. On 14th March 2017, the physician notified the parents of the patient that the allergist determined no future contraindication. The planned age was 16 to have the patient return and be monitored for 20 minutes after vaccination. On 18th March 2017, 9 days after vaccination, the patient was seen at an urgent care for left eye conjunctivitis, as noted by the nurse caller.
Pt recvd 3 doses of Engerix-B; found to have no detectable titers;
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. The patients medical history was not reported. In June 2015 (reported as since 10-JUN-2015), the patient were administered doses of improperly stored PROQUAD (Merck), (lot #, dose and site of administration were not reported) subcutaneously. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with ROTATEQ (lot # L008054, expiration date: 30-NOV-2016, orally, dose was not reported). Concomitant drug was not reported. The vaccines were at 29 F for 648 minutes and 55 F for 360 minutes because of data logger issue. There was no previous temperature excursion. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
I developed genital herpes - in less than 2 mos. I then was diag with subcorneal pustular dermatosis 2009 - and urticaria in neck and face.
Pt recvd measles vax 19FEB91 & 24 hrs following vax pt devel generalized pruritus; tx DPH & @ time of the report pt was recovering;
VARIVAX imm. 7/14/19. Went to ER 7/16/19 AM with 2 blisters and lg. red area lower lip, chin and cheek. Teeth hurt on that side, itching. Dx with shingles.
Per NP, patient reported that she had developed tingling and itching around mouth 15 to 30 minutes after first intradermal JYNNEOS vaccine 1 month ago.  NP discussed option to not take second dose, patient stated that she prefered taking second dose, itching subsided when took Benadryl after first dose, second dose administered at 11:26 AM, patient sat in waiting area, started exoeriencing itching on scalp at 11:30 AM, patient took one Benadryl she had brought from home at 11:46 AM, patient informed NP itching appeared to be bothering her more and took a second Benadryl 25 mg po that she had brought with her, patient drove herself to clinic, 12:00 PM no rash or hives noted by NP, patient described feeling tingling but states ok to drive home, left clinic at 12:15 PM, NP informed patient she would call her.  NP called patient at 12:42 PM, no answer at that time, NP called patient a second time at 12:59 PM, reached patient who reported she felt well, no further tingling or itching.
Big rash at the injection site; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Big rash at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 17-Feb-2021, the patient experienced INJECTION SITE RASH (Big rash at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Big rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Antibiotics
After a 7 day (Oct 22-28) cruise, woke up to a fever 100.4F, cough, sore throat on the morning of Oct 31. Did covid test with a home kit and confirmed positive.  My LVN son also confirmed the result with a second test. Reported thru evisit to clinic and was offered an intravenous treatment or a new tab paxlovid which I both refused.  I took 2 doses of 2 tabs 1200mg tylenol 24 hours apart. As of this writing, 11/04/22, am feeling good except for residual cough with phlegm.  Still alive.
Patient moved and leg got scratched. Also rash on leg and spread to arms and on face.
Pt. developed a severe case of shingles approx 1 day after receiving a 2nd Varicella vaccine.
Patient received 0.3mL of Comirnaty in left arm on 9/30/23 with no events noted on day of administration. Patient later called and spoke with the pharmacist on 10/18/23 complaining of arm and chest pain on left side since receiving the vaccine. Since his symptoms are more indicative of a cardiac event vs vaccine, pharmacist recommended patient seek medical attention. Patient's representative called back on 10/25/23 to discuss the same symptoms and confirmed that the patient had not gone to hospital or provider since the last call. I informed the representative that we would report the event, but strongly recommended that she take the patient to be seen and evaluated for possible cardiac events. I asked that she update the pharmacy after he is seen so we can update our report.
Pt. states that after receiving the 2nd dose of Moderna 03/13/2021, started experiencing symptoms 04/13/2021 of shortness of breath lasting 5 days, Primary communications recommendation for Emergency Room visit 04/20/2021 Blood Work suggested Heart Attack.
8 days after vaccination the arm which received injection (upper right arm)  developed a large 3x4 inch itchy red rash.  The rash hast lasted over 24 hours without significant change at this point.   No fever or other symptoms.
Child developed hives went to hospital for evaluation & advised not to get 2nd dose this year.
woke up from nap p/receiving shot (had napped 1 1/2hr) crying & cried unconsolably for 4 hr;